PPARγ gene therapy targets PPARγ to improve insulin sensitivity and lipid metabolism in individuals with metabolic syndrome, offering a potential cure for disorders stemming from PPARγ dysfunction [253]. This evidence concerns the gene INS and metabolic syndrome.